… –risk ratio of remdesivir. Current review was planned to assess the mortality and clinical
benefit in addition to safety of remdesivir in the treatment of COVID-19 caused by SARS-CoV-2. …

… In conclusion, remdesivir is a safe form of treatment for COVID-19, with a small number of
side effects that in the vast majority of cases do not require discontinuation of treatment; yet, the …

… In summary, we generated hPSC-CMs to evaluate anti-SARS-CoV-2 activity as well as the
safety of remdesivir in physiologically and disease-relevant human cells. This study provides …

… safety profiles have made favipiravir (FVP) and remdesivir (RDV) promising therapeutic options
for use against severe acute respiratory syndrome coronavirus 2 (SARS-CoV… SARS-CoV-…

… Safety and Cardiac Rhythm Abnormalities There were 133 patients included in the study of
Remdesivir heart safety, … of our work was to describe the safety of Remdesivir in terms of drug-…

… respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a serious threat to the global
public health. There is an urgent demand for safe and effective therapeutics. Remdesivir, a …

… from the CARAVAN study, this review allows more information to be gathered regarding
the safety and efficacy of a shorter duration of remdesivir therapy in pediatric patients with …

… of SARS-CoV infection, potent antiviral activity against SARS-CoV-2, acceptable safety profile
of parenteral remdesivir … virus disease, the clinical use of remdesivir in the cases of COVID-…

… We have performed a systematic search in the PubMed, Google Scholar and Cochrane
Library using specific keywords such as ‘COVID-19’ OR ‘SARS CoV-2’ AND ‘Remdesivir’. The …

… One of the more noteworthy findings in this study is that MD simulation analysis that saquinavir,
ritonavir, and remdesivir can form stable interaction inside the binding site of SARS-CoV-…